CLOSURE OF DEAD SPACE AFTER MODIFIED RADICAL MASTECTOMY: DOES IT REDUCE THE INCIDENCE OF SEROMA?




Unless Something Goes Wrong: Making Art to Understand and Mitigate the Risk of Therapeutic Inertia in the Treatment of Multiple Sclerosis

In the long-term management of a degenerative illness there is Plug a risk that the approach we take to treatment can be characterized by therapeutic inertia (TI).With no evidence of disease progression clinicians can be reluctant to make a change to treatment regimes.This can lead to less choice and suboptimal outcomes for people with multiple scl

read more